MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
issuance of common stock...
$500,037K
(14.99%↑ Y/Y)
Proceeds from issuance of
common stock-At Market...
$104,528K
(142.90%↑ Y/Y)
Proceeds from exercise of
warrants
$7,315K
(1123.24%↑ Y/Y)
Proceeds received
related to employee...
$5,653K
(106.62%↑ Y/Y)
Net cash provided by
financing activities
$617,533K
(61.99%↑ Y/Y)
Effect of exchange
rates on cash and cash...
$102K
(666.67%↑ Y/Y)
Increase (decrease) in
cash, cash...
$120,395K
(256.60%↑ Y/Y)
Canceled cashflow
$497,240K
Stock-based compensation
$732,420K
(1336.65%↑ Y/Y)
Accounts payable
$15,303K
(659.45%↑ Y/Y)
Accrued liabilities and
other current...
$12,930K
(8.85%↑ Y/Y)
Prepaid expenses and
other current assets
-$4,866K
(-161.56%↓ Y/Y)
Accrued compensation
$2,909K
(-55.64%↓ Y/Y)
Operating lease
right-of-use assets and lease...
$203K
(221.56%↑ Y/Y)
Depreciation
$146K
(64.04%↑ Y/Y)
Other long-term
liabilities
$80K
(-15.79%↓ Y/Y)
Maturities and sales of
short-term investments
$311,340K
(-36.44%↓ Y/Y)
Net cash used in
operating activities
-$322,930K
(-127.25%↓ Y/Y)
Net cash used in
investing activities
-$174,310K
(15.11%↑ Y/Y)
Canceled cashflow
$768,857K
Canceled cashflow
$311,340K
Net loss
-$1,079,586K
(-387.81%↓ Y/Y)
Purchase of short-term
investments
$484,993K
(-28.68%↓ Y/Y)
Amortization of discount on
short-term investments
$7,006K
(171.97%↑ Y/Y)
Other assets
$4,875K
(297.37%↑ Y/Y)
Unrealized foreign
exchange loss (gain)
$320K
(239.74%↑ Y/Y)
Purchase of property and
equipment
$657K
(372.66%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)